ONYX PHARMACEUTICALS INC's ticker is and the CUSIP is 683399AB5. A total of 20 filers reported holding ONYX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $3,115,000 | – | 1,368,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 40,380,000 | $129,999,000 | 12.29% |
| GLAZER CAPITAL, LLC | 6,785,000 | $21,895,000 | 6.50% |
| WHITEBOX ADVISORS LLC | 23,848,000 | $76,525,000 | 4.04% |
| ANGELO GORDON & CO., L.P. | 11,500,000 | $36,843,000 | 2.38% |
| Kohlberg Kravis Roberts & Co. L.P. | 32,877,000 | $105,206,000 | 1.99% |
| Polar Asset Management Partners Inc. | 7,500,000 | $24,061,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 8,035,000 | $25,801,000 | 0.53% |
| D. E. Shaw & Co., Inc. | 35,580,000 | $114,163,000 | 0.18% |
| AQR Capital Management | 11,885,000 | $38,136,000 | 0.13% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,104,000 | $6,741,000 | 0.07% |